Skip to main content
. 2022 Mar 3;48(4):467–478. doi: 10.1007/s00134-022-06645-w
Extracorporeal membrane oxygenation (ECMO) has been used widely throughout the coronavirus disease 2019 (COVID-19) pandemic, however, conflicting outcomes have been reported. We found that in a well-matched cohort of ECMO-referred patients, retrieval on mobile ECMO to a specialist center conferred survival benefit.